Advertisement

Heart Transplantation

  • Josef ThulEmail author
  • Dietrich Klauwer
Chapter

Abstract

The pediatric heart transplantation Chap. 17 deals with indications, preparations, and preoperative management of recipient and donor while addressing the medical treatment of children undergoing heart transplantation. Besides routine posttransplant treatment of the recipient, preemptive therapy and diagnostic investigations of complex complications are described with respect to hemodynamics, immunosuppression, and infectious diseases. Special emphasis is placed on rejection, posttransplant systemic hypertension, pulmonary hypertension, and AB0-incompatible transplantation in children.

Suggested Reading

  1. 1.
    Dipchand AI, et al. Equivalent outcomes for pediatric heart transplant recipients: ABO-blood group incompatible versus ABO-compatible. Am J Transplant. 2010;10(2):389–97.CrossRefGoogle Scholar
  2. 2.
    Hoskote A, et al. Acute right ventricular failure after pediatric cardiac transplant: predictors and long term outcome in current era of transplantation medicine. Thorac Cardiovasc Surg. 2010;139:146–53.CrossRefGoogle Scholar
  3. 3.
    Irving CA, et al. Immunosuppression therapy for pediatric heart transplantation. Curr Treat Options Cardiovasc Med. 2010;12:489. ffCrossRefGoogle Scholar
  4. 4.
    ISHLT Monograph Series (2007) Pediatric heart transplantation, Vol. 2. Amsterdam: Elsevier.Google Scholar
  5. 5.
    Pollock-Barziv SM et al., Pediatric heart transplantation in human leucocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population. Circulation (2007); 116(11Suppl): I 172 ff.CrossRefGoogle Scholar
  6. 6.
    Schwartz GJ. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629–37.CrossRefGoogle Scholar
  7. 7.
    Urschel S, et al. Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age? Am J Transplant. 2010;10(1):149–56.CrossRefGoogle Scholar
  8. 8.
    Vaudry W. Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients. Am J Transplant. 2009;9:636–43.CrossRefGoogle Scholar
  9. 9.
    Webber SA, et al. Heart and lung transplantation in children. Lancet. 2006;368:53–69.CrossRefGoogle Scholar
  10. 10.
    West LJ, et al. ABO-incompatible heart transplantation in infants. N Engl J Med. 2001;344(11):793–800.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Pediatric Intensive Care Unit, Pediatric Heart Center of Giessen, Children’s Heart Transplantation Center, UKGM GmbHGiessenGermany
  2. 2.Department of PediatricsSingen Medical Center, Gesundheitsverbund Landkreis Konstanz, Krankenhausbetriebsgesellschaft Hegau-Bodensee-KlinikumSingenGermany

Personalised recommendations